Advertisement

IIT team identifies sustainable source for anti-cancer drug

Follow The Hawk on Google News+ Follow

Advertisement


Chennai: Indian Institute of Technology (IIT) Madras researchers have identified a sustainable and high-yielding alternative source for the anti-cancer drug Camptothecin.

At present, this drug is sourced from Chinese and Indian tree species, which are now critically endangered due to extensive over-harvesting to meet the market demand.

Advertisement

This novel microbial fermentation process can be an economically efficient and sustainable method of production to fulfil the market demand on a large scale, according to a paper published in the reputed peer-reviewed International Journal of Scientific Reports.

Also readFSSAI to initiate action against Bisleri over unsafe water sample

"The novelty of the work lies in the fact that unlike other potential microbial strains reported, this strain has been found to show sustainable production even beyond 100 generations," said researcher Smita Srivastava, Associate Professor, Department of Biotechnology, IIT Madras.

"The plan now is to use the isolated novel strain for the development of a microbial fermentation based sustainable bioprocess for large scale in vitro production of Camptothecin, preferably in collaboration with interested industrial partner(s)," Srivastava added.

Advertisement

Topotecan and Irinotecan are two widely used anticancer drugs, which are produced by using Camptothecin as the lead molecule. More than a dozen derivatives and conjugates of Camptothecin are under various stages of clinical trials for anti-cancer applications.

Also read'Fatty liver-free campaign' in Ranchi from Nov 23, MoS Sanjay Seth to take lead

Camptothecin is an alkaloid isolated from the Chinese tree Camptotheca acuminata and the Indian tree Nothapodytes nimmoniana. Nearly 1,000 tons of plant material is required to extract just one ton of Camptothecin.

Due to extensive over-harvesting to meet the market demand both these plants are now critically endangered. The N. nimmoniana population has seen more than a 20% decline in the last decade alone.

Cancer has been a leading cause of death worldwide including in India. It is projected that by 2026, the new cancer cases in India annually would reach 0.93 million in male and 0.94 million in female patients, according to a study published in the Asian Pacific Journal of Cancer Prevention.

—IANS

Get The Hawk first on Google

Add The Hawk as a preferred source and Google shows you more of our stories in Top Stories. Follow us on Google News too.

Share this story

Advertisement

India eyes space-based drug development as scientists, startups explore microgravity researchRead next →India eyes space-based drug development as scientists, startups explore microgravity researchHealth · 22 Nov 2026, 03:08 PM IST